comparemela.com

Latest Breaking News On - Insider activity at eyepoint pharmaceuticals - Page 2 : comparemela.com

EyePoint Pharmaceuticals (NASDAQ:EYPT) Coverage Initiated at JPMorgan Chase & Co

Investment analysts at JPMorgan Chase & Co. assumed coverage on shares of EyePoint Pharmaceuticals (NASDAQ:EYPT – Get Free Report) in a report issued on Monday, MarketBeat reports. The firm set an “overweight” rating and a $35.00 price target on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 40.51% from the […]

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Down 5%

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report)’s share price dropped 5% during trading on Tuesday . The stock traded as low as $18.60 and last traded at $18.97. Approximately 170,137 shares traded hands during mid-day trading, a decline of 78% from the average daily volume of 780,024 shares. The stock had previously closed at […]

EyePoint Pharmaceuticals (NASDAQ:EYPT) Receives Overweight Rating from Cantor Fitzgerald

EyePoint Pharmaceuticals (NASDAQ:EYPT – Get Free Report)‘s stock had its “overweight” rating reiterated by analysts at Cantor Fitzgerald in a research report issued to clients and investors on Thursday, Benzinga reports. They presently have a $31.00 target price on the stock. Cantor Fitzgerald’s target price suggests a potential upside of 207.23% from the company’s current […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.